Cover Image
Market Research Report

Global PDX Models Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Published by Data Bridge Market Research Private Limited Product code 674772
Published Content info 200 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global PDX Models Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Published: July 1, 2018 Content info: 200 Pages
Description

Global PDX models market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for global PDX models market are listed below:

  • Crown Bioscience Inc.
  • The Jackson Laboratory
  • Champion Oncology, Inc.
  • Charles River
  • Oncodesign
  • Wuxi AppTec
  • Horizon Discovery Group plc
  • Pharmatest Services
  • Hera Biolabs
  • EPO Berlin-Buch GmbH
  • Xentech
  • Urolead
  • Creative Animodel
  • EUROPDX
  • MI Bioresearch Inc
  • Aragen Bioscience

The market is further segmented into:

  • Type
  • Tumor Type
  • Application
  • End User

The global PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.

The global PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The global PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The global PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into 5 geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global PDX models market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION 16

  • 1.1 OBJECTIVES OF THE STUDY 16
  • 1.2 MARKET DEFINITION 16
  • 1.3 OVERVIEW OF GLOBAL PDX MODELS MARKET 16
  • 1.4 CURRENCY AND PRICING 17
  • 1.5 LIMITATION 17
  • 1.6 MARKETS COVERED 17

2 MARKET SEGMENTATION 19

  • 2.1 MARKETS COVERED 19
  • 2.2 GEOGRAPHIC SCOPE 20
  • 2.3 YEARS CONSIDERED FOR THE STUDY 20
  • 2.4 CURRENCY AND PRICING 21
  • 2.5 RESEARCH METHODOLOGY 22
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
  • 2.7 SECONDARY SOURCES 26
  • 2.8 ASSUMPTIONS 26

3 MARKET OVERVIEW 27

  • 3.1 DRIVERS 29
    • 3.1.1 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH 29
    • 3.1.2 PDX MODELS OFFER ADVANTAGES AS COMPARED WITH THE CLASSIC APPROACH 31
    • 3.1.3 RISING NEED FOR PERSONALIZED MEDICINE 32
    • 3.1.4 INCREASING SUPPORT FOR CANCER RESEARCH ACTIVITIES FROM GOVERNMENT AND NON-GOVERNMENT ORGANIZATION 32
  • 3.2 RESTRAINTS 33
    • 3.2.1 HIGH COST OF PDX MODELS 33
    • 3.2.2 STRICT REGULATION WITH RESPECT TO THE UTILIZATION OF ANIMAL MODELS IN CANCER RESEARCH 33
  • 3.3 OPPRTUNITIES 34
    • 3.3.1 INCREASING DEMAND FOR HUMANIZED PDX MODELS 34
  • 3.4 CHALLENGES 35
    • 3.4.1 LIMITATIONS OF PDX MODELS 35

4 EXECUTIVE SUMMARY 36

5 PREMIUM INSIGHTS 39

6 GLOBAL PDX MODELS MARKET, BY TYPE 42

  • 6.1 OVERVIEW 43
  • 6.2 MICE MODELS 45
  • 6.3 RAT MODELS 46

7 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE 47

  • 7.1 OVERVIEW 48
  • 7.2 GASTROINTESTINAL TUMOR MODELS 50
  • 7.3 GYNECOLOGICAL TUMOR MODELS 51
  • 7.4 RESPIRATORY TUMOR MODELS 52
  • 7.5 UROLOGICAL TUMOR MODELS 53
  • 7.6 HEMATOLOGICAL TUMOR MODELS 54
  • 7.7 OTHERS 55

8 GLOBAL PDX MODELS MARKET, BY APPLICATION 56

  • 8.1 OVERVIEW 57
  • 8.2 PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH 59
  • 8.3 BIOMARKER ANALYSIS 60

9 GLOBAL PDX MODELS MARKET, BY END USER 61

  • 9.1 OVERVIEW 62
  • 9.2 CONTRACT RESEARCH ORGANIZATIONS 64
  • 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 65
  • 9.4 ACADEMIC AND RESEARCH INSTITUTIONS 66

10 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY 67

  • 10.1 OVERVIEW 68
  • 10.2 NORTH AMERICA 75
    • 10.2.1 U.S. 83
    • 10.2.2 CANADA 85
    • 10.2.3 MEXICO 87
  • 10.3 EUROPE 89
    • 10.3.1 GERMANY 97
    • 10.3.2 FRANCE 99
    • 10.3.3 U.K. 101
    • 10.3.4 ITALY 103
    • 10.3.5 SPAIN 105
    • 10.3.6 SWITZERLAND 107
    • 10.3.7 NETHERLANDS 109
    • 10.3.8 TURKEY 111
    • 10.3.9 BELGIUM 113
    • 10.3.10 RUSSIA 115
    • 10.3.11 REST OF EUROPE 117
  • 10.4 ASIA PACIFIC 118
    • 10.4.1 JAPAN 126
    • 10.4.2 CHINA 128
    • 10.4.3 INDIA 130
    • 10.4.4 SOUTH KOREA 132
    • 10.4.5 AUSTRALIA 134
    • 10.4.6 SINGAPORE 136
    • 10.4.7 THAILAND 138
    • 10.4.8 MALAYSIA 140
    • 10.4.9 INDONESIA 143
    • 10.4.10 PHILIPPINES 145
    • 10.4.11 REST OF ASIA PACIFIC 147
  • 10.5 SOUTH AMERICA 148
    • 10.5.1 BRAZIL 156
    • 10.5.2 REST OF SOUTH AMERICA 158
  • 10.6 MIDDLE EAST AND AFRICA 159
    • 10.6.1 SOUTH AFRICA 167
    • 10.6.2 REST OF MIDDLE EAST AND AFRICA 169

11 GLOBAL PDX MODELS MARKET, COMPANY LANDSCAPE 170

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL 170
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 171
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE 172
  • 11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC 173

12 COMPANY PROFILES 174

  • 12.1 CHARLES RIVER 174
    • 12.1.1 COMPANY OVERVIEW 174
    • 12.1.2 REVENUE ANALYSIS 174
    • 12.1.3 COMPANY SHARE ANALYSIS 175
    • 12.1.4 PRODUCT PORTFOLIO 175
    • 12.1.5 RECENT DEVELOPMENTS 175
  • 12.2 CROWN BIOSCIENCE INC. (SUBSIDIARY OF JSR CORPORATION) 176
    • 12.2.1 COMPANY OVERVIEW 176
    • 12.2.2 GEOGRAPHIC PRESENCE 176
    • 12.2.3 COMPANY SHARE ANALYSIS 177
    • 12.2.4 PRODUCT PORTFOLIO 177
    • 12.2.5 RECENT DEVELOPMENTS 178
  • 12.3 CHAMPION ONCOLOGY, INC 179
    • 12.3.1 COMPANY OVERVIEW 179
    • 12.3.2 REVENUE ANALYSIS 179
    • 12.3.3 COMPANY SHARE ANALYSIS 180
    • 12.3.4 PRODUCT PORTFOLIO 180
    • 12.3.5 RECENT DEVELOPMENTS 180
  • 12.4 ARAGEN BIOSCIENCE (SUBSIDIARY OF GVK BIOSCIENCES PRIVATE LIMITED) 181
    • 12.4.1 COMPANY OVERVIEW 181
    • 12.4.2 PRODUCT PORTFOLIO 181
    • 12.4.3 RECENT DEVELOPMENTS 181
  • 12.5 CREATIVE ANIMODEL 182
    • 12.5.1 COMPANY OVERVIEW 182
    • 12.5.2 PRODUCT PORTFOLIO 182
    • 12.5.3 RECENT DEVELOPMENTS 182
  • 12.6 EPO BERLIN-BUCH GMBH 183
    • 12.6.1 COMPANY OVERVIEW 183
    • 12.6.2 PRODUCT PORTFOLIO 183
    • 12.6.3 RECENT DEVELOPMENTS 183
  • 12.7 EUROPDX 184
    • 12.7.1 COMPANY OVERVIEW 184
    • 12.7.2 GEOGRAPHICAL PRESENCE 184
    • 12.7.3 PRODUCT PORTFOLIO 185
    • 12.7.4 RECENT DEVELOPMENTS 185
  • 12.8 HERA BIOLABS 186
    • 12.8.1 COMPANY OVERVIEW 186
    • 12.8.2 PRODUCT PORTFOLIO 186
    • 12.8.3 RECENT DEVELOPMENTS 186
  • 12.9 HORIZON DISCOVERY GROUP PLC 187
    • 12.9.1 COMPANY OVERVIEW 187
    • 12.9.2 REVENUE ANALYSIS 187
    • 12.9.3 PRODUCT PORTFOLIO 188
    • 12.9.4 RECENT DEVELOPMENTS 188
  • 12.10 MI BIORESEARCH INC 189
    • 12.10.1 COMPANY OVERVIEW 189
    • 12.10.2 PRODUCT PORTFOLIO 189
    • 12.10.3 RECENT DEVELOPMENTS 189

  • 12.11 ONCODESIGN 190
    • 12.11.1 COMPANY OVERVIEW 190
    • 12.11.2 REVENUE ANALYSIS 190
    • 12.11.3 PRODUCT PORTFOLIO 191
    • 12.11.4 RECENT DEVELOPMENTS 191
  • 12.12 PHARMATEST SERVICES LTD 192
    • 12.12.1 COMPANY OVERVIEW 192
    • 12.12.2 GEOGRAPHIC PRESENCE 192
    • 12.12.3 PRODUCT PORTFOLIO 193
    • 12.12.4 RECENT DEVELOPMENTS 193
  • 12.13 THE JACKSON LABORATORY 194
    • 12.13.1 COMPANY OVERVIEW 194
    • 12.13.2 REVENUE ANALYSIS 194
    • 12.13.3 PRODUCT PORTFOLIO 195
    • 12.13.4 RECENT DEVELOPMENTS 195
  • 12.14 UROLEAD 196
    • 12.14.1 COMPANY OVERVIEW 196
    • 12.14.2 PRODUCT PORTFOLIO 196
    • 12.14.3 RECENT DEVELOPMENTS 196
  • 12.15 WUXI APPTEC 197
    • 12.15.1 COMPANY OVERVIEW 197
    • 12.15.2 GEOGRAPHIC PRESENCE 197
    • 12.15.3 PRODUCT PORTFOLIO 198
    • 12.15.4 RECENT DEVELOPMENTS 198
  • 12.16 XENTECH 199
    • 12.16.1 COMPANY OVERVIEW 199
    • 12.16.2 PRODUCT PORTFOLIO 199
    • 12.16.3 RECENT DEVELOPMENTS 199

13 RELATED REPORTS 200

LIST OF TABLES

  • TABLE 1 GLOBAL PDX MODELS MARKET, BY TYPE, 2016- 2025, (USD MILLION) 44
  • TABLE 2 GLOBAL MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 45
  • TABLE 3 GLOBAL RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 46
  • TABLE 4 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2016- 2025 (USD MILLION) 49
  • TABLE 5 GLOBAL GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 50
  • TABLE 6 GLOBAL GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 51
  • TABLE 7 GLOBAL RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 52
  • TABLE 8 GLOBAL UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 53
  • TABLE 9 GLOBAL HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 54
  • TABLE 10 GLOBAL OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 55
  • TABLE 11 GLOBAL PDX MODELS MARKET, BY APPLICATION, 2016- 2025 (USD MILLION) 58
  • TABLE 12 GLOBAL PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 59
  • TABLE 13 GLOBAL BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 60
  • TABLE 14 GLOBAL PDX MODELS MARKET, BY END USER, 2016- 2025, (USD MILLION) 63
  • TABLE 15 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION) 64
  • TABLE 16 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 65
  • TABLE 17 GLOBAL ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION) 66
  • TABLE 18 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY, 2016 - 2025, (USD MILLION) 74
  • TABLE 19 NORTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016 - 2025, (USD MILLION) 80
  • TABLE 20 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 80
  • TABLE 21 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 81
  • TABLE 22 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 81
  • TABLE 23 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 82
  • TABLE 24 U.S. PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 83
  • TABLE 25 U.S. PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 83
  • TABLE 26 U.S. PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 84
  • TABLE 27 U.S. PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 84
  • TABLE 28 CANADA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 85
  • TABLE 29 CANADA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 85
  • TABLE 30 CANADA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 86
  • TABLE 31 CANADA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 86
  • TABLE 32 MEXICO PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 87
  • TABLE 33 MEXICO PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 87
  • TABLE 34 MEXICO PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 88
  • TABLE 35 MEXICO PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 88
  • TABLE 36 EUROPE PDX MODELS MARKET, BY COUNTRY , 2016 - 2025 (USD MILLION) 94
  • TABLE 37 EUROPE PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 95
  • TABLE 38 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 95
  • TABLE 39 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 96
  • TABLE 40 EUROPE PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 96
  • TABLE 41 GERMANY PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 97
  • TABLE 42 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 97
  • TABLE 43 GERMANY PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 98
  • TABLE 44 GERMANY PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 98
  • TABLE 45 FRANCE PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 99
  • TABLE 46 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 99
  • TABLE 47 FRANCE PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 100
  • TABLE 48 FRANCE PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 100
  • TABLE 49 U.K. PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 101
  • TABLE 50 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 101
  • TABLE 51 U.K. PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 102
  • TABLE 52 U.K. PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 102
  • TABLE 53 ITALY PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 103
  • TABLE 54 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 103
  • TABLE 55 ITALY PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 104
  • TABLE 56 ITALY PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 104
  • TABLE 57 SPAIN PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 105
  • TABLE 58 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 105
  • TABLE 59 SPAIN PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 106
  • TABLE 60 SPAIN PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 106
  • TABLE 61 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 107
  • TABLE 62 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 107
  • TABLE 63 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 108
  • TABLE 64 SWITZERLAND PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 108
  • TABLE 65 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 109
  • TABLE 66 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 109
  • TABLE 67 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 110
  • TABLE 68 NETHERLANDS PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 110
  • TABLE 69 TURKEY PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 111
  • TABLE 70 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 111
  • TABLE 71 TURKEY PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 112
  • TABLE 72 TURKEY PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 112
  • TABLE 73 BELGIUM PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 113
  • TABLE 74 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 113
  • TABLE 75 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 114
  • TABLE 76 BELGIUM PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 114
  • TABLE 77 RUSSIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 115
  • TABLE 78 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 115
  • TABLE 79 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 116
  • TABLE 80 RUSSIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 116
  • TABLE 81 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 117
  • TABLE 82 ASIA PACIFIC PDX MODELS MARKET, BY COUNTRY , 2016 - 2025, (USD MILLION) 123
  • TABLE 83 ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 124
  • TABLE 84 ASIA PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 124
  • TABLE 85 ASIA PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 125
  • TABLE 86 ASIA PACIFIC PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 125
  • TABLE 87 JAPAN PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 126
  • TABLE 88 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 126
  • TABLE 89 JAPAN PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 127
  • TABLE 90 JAPAN PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 127
  • TABLE 91 CHINA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 128
  • TABLE 92 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 128
  • TABLE 93 CHINA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 129
  • TABLE 94 CHINA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 129
  • TABLE 95 INDIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 130
  • TABLE 96 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 130
  • TABLE 97 INDIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 131
  • TABLE 98 INDIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 131
  • TABLE 99 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 132
  • TABLE 100 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 132
  • TABLE 101 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 133
  • TABLE 102 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 133
  • TABLE 103 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 134
  • TABLE 104 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 134
  • TABLE 105 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 135
  • TABLE 106 AUSTRALIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 135
  • TABLE 107 SINGAPORE PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 136
  • TABLE 108 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 136
  • TABLE 109 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 137
  • TABLE 110 SINGAPORE PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 137
  • TABLE 111 THAILAND PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 138
  • TABLE 112 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 138
  • TABLE 113 THAILAND PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 139
  • TABLE 114 THAILAND PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 139
  • TABLE 115 MALAYSIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 140
  • TABLE 116 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 141
  • TABLE 117 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 141
  • TABLE 118 MALAYSIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 142
  • TABLE 119 INDONESIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 143
  • TABLE 120 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 143
  • TABLE 121 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 144
  • TABLE 122 INDONESIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 144
  • TABLE 123 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 145
  • TABLE 124 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 145
  • TABLE 125 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 146
  • TABLE 126 PHILIPPINES PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 146
  • TABLE 127 REST OF ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 147
  • TABLE 128 SOUTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION) 153
  • TABLE 129 SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 153
  • TABLE 130 SOUTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 154
  • TABLE 131 SOUTH AMERICA IN PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 154
  • TABLE 132 SOUTH AMERICA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 155
  • TABLE 133 BRAZIL PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION) 156
  • TABLE 134 BRAZIL PDX MODEL MARKET, BY TUMOR TYPE, 2016 - 2025 (USD MILLION) 156
  • TABLE 135 BRAZIL PDX MODELS MARKET, BY APPLICATION , 2016 - 2025 (USD MILLION) 157
  • TABLE 136 BRAZIL PDX MODEL MARKET, BY END USER, 2016 - 2025 (USD MILLION) 157
  • TABLE 137 REST OF SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION) 158
  • TABLE 138 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION) 164
  • TABLE 139 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 164
  • TABLE 140 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 165
  • TABLE 141 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 165
  • TABLE 142 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 166
  • TABLE 143 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 167
  • TABLE 144 SOUTH AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 167
  • TABLE 145 SOUTH AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 168
  • TABLE 146 SOUTH AFRICA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 168
  • TABLE 147 REST OF MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016-2025, (USD MILLION) 169

LIST OF FIGURES

  • FIGURE 1 GLOBAL PDX MODELS MARKET: SEGMENTATION 19
  • FIGURE 2 GLOBAL PDX MODELS MARKET: DATA TRIANGULATION 22
  • FIGURE 3 GLOBAL PDX MODELS MARKET: RESEARCH SNAPSHOT 23
  • FIGURE 4 GLOBAL PDX MODELS MARKET : BOTTOM UP APPROACH 24
  • FIGURE 5 GLOBAL PDX MODELS MARKET : TOP DOWN APPROACH 24
  • FIGURE 6 GLOBAL PDX MODELS MARKET: INTERVIEW DEMOGRAPHICS 25
  • FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PDX MODELS MARKET 28
  • FIGURE 8 BELOW MENTIONED IS R&D EXPENSE BY THE JACKSON LABORATORY FOR YEAR 2016-17: 30
  • FIGURE 9 GLOBAL PDX MODELS MARKET: SEGMENTATION 37
  • FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE PDX MODELS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 38
  • FIGURE 11 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH AND RISING NEED FOR PERSONALIZED MEDICINE ARE EXPECTED TO DRIVE THE MARKET FOR PDX MODELS IN THE FORECAST PERIOD 2018 TO 2025 39
  • FIGURE 12 MICE MODELS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PDX MODELS MARKET IN 2018 & 2025 40
  • FIGURE 13 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR PDX MODELS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 41
  • FIGURE 14 GLOBAL PDX MODELS MARKET: BY TYPE, 2017 43
  • FIGURE 15 GLOBAL PDX MODELS MARKET: BY TYUMOR TYPE, 2017 48
  • FIGURE 16 GLOBAL PDX MODELS MARKET: BY APPLICATION, 2017 57
  • FIGURE 17 GLOBAL PDX MODELS MARKET: BY END USER, 2017 62
  • FIGURE 18 GLOBAL PDX MODELS MARKET: SNAPSHOT (2017) 69
  • FIGURE 19 GLOBAL PDX MODELS MARKET: BY GEOGRAPHY (2017) 70
  • FIGURE 20 GLOBAL PDX MODELS MARKET: BY GEOGRAPHY (2018 & 2025) 71
  • FIGURE 21 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY (2017 & 2025) 72
  • FIGURE 22 GLOBAL PDX MODELS MARKET, BY TYPE (2018 - 2025) 73
  • FIGURE 23 NORTH AMERICA PDX MODELS MARKET SNAPSHOT (2017) 75
  • FIGURE 24 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017) 76
  • FIGURE 25 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025) 77
  • FIGURE 26 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 78
  • FIGURE 27 NORTH AMERICA PDX MODELS MARKET, BY TYPE (2018 - 2025) 79
  • FIGURE 28 EUROPE PDX MODELS MARKET SNAPSHOT (2017) 89
  • FIGURE 29 EUROPE PDX MODELS MARKET: BY COUNTRY (2017) 90
  • FIGURE 30 EUROPE PDX MODELS MARKET: BY COUNTRY (2018 & 2025) 91
  • FIGURE 31 EUROPE PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 92
  • FIGURE 32 EUROPE PDX MODELS MARKET: BY TYPE (2018-2025) 93
  • FIGURE 33 ASIA PACIFIC PDX MODELS MARKET SNAPSHOT (2017) 118
  • FIGURE 34 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2017) 119
  • FIGURE 35 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2018 & 2025) 120
  • FIGURE 36 ASIA PACIFIC PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 121
  • FIGURE 37 ASIA PACIFIC PDX MODELS MARKET : BY TYPE (2018-2025) 122
  • FIGURE 38 SOUTH AMERICA PDX MODELS MARKET SNAPSHOT (2017) 148
  • FIGURE 39 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017) 149
  • FIGURE 40 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025) 150
  • FIGURE 41 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 151
  • FIGURE 42 SOUTH AMERICA PDX MODELS MARKET, BY TYPE (2018 - 2025) 152
  • FIGURE 43 MIDDLE EAST AND AFRICA PDX MODELS MARKET SNAPSHOT (2017) 159
  • FIGURE 44 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2017) 160
  • FIGURE 45 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025) 161
  • FIGURE 46 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 162
  • FIGURE 47 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE (2018 - 2025) 163
  • FIGURE 48 GLOBAL PDX MODELS MARKET: COMPANY SHARE 2017 (%) 170
  • FIGURE 49 NORTH AMERICA PDX MODELS MARKET: COMPANY SHARE 2017(%) 171
  • FIGURE 50 EUROPE PDX MODELS MARKET: COMPANY SHARE 2017 (%) 172
  • FIGURE 51 ASIA-PACIFIC PDX MODELS MARKET: COMPANY SHARE 2017 (%) 173
Back to Top